CPT 00148: Anesthesia for Ophthalmoscopy
Commercial payers pay $73 on average nationally for this procedure.
CPT code 00148 describes anesthesia services provided for a patient undergoing an ophthalmoscopy, indicating perioperative anesthesia care for an eye diagnostic or procedural ophthalmic examination; service type: anesthesia for ophthalmic procedure; typical site of service: ambulatory surgery center or hospital outpatient/inpatient surgical setting where ophthalmic procedures are performed.
For related coverage guidance, see recent payer policy updates: Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders, Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders, Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders.
Customize your policy alerts
Sign up for cpt 00148 policy alerts
Get alerted when payer policies referencing 00148 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Across national commercial payers, the BUCA average commercial rate of $73.10 sits near the middle of the insurer distribution, with Cigna ($91.20 mean) and Blue Cross Blue Shield ($72.60 mean) on the higher side of averages and Aetna ($61.60 mean) and UnitedHealth Group ($67.90 mean) slightly lower. Blue Cross Blue Shield reaches a high maximum ($216.70) while Cigna also shows elevated upper-end rates ($165.30), indicating greater potential variability above the BUCA average; Aetna’s and UnitedHealth Group’s maximums are more modest at $154.40 and $122.70, respectively.
Examining interquartile dispersion (P75 minus P25) highlights who is tightest and widest: Blue Cross Blue Shield has a spread of $38.70 (from $51.20 to $94.90), UnitedHealth Group is relatively tight at $29.10 (from $52.00 to $81.10), and Aetna’s spread is $40.20 (from $42.00 to $81.20). Cigna shows the widest IQR at $40.90 (from $67.00 to $107.60), suggesting the most middle-range variability among these commercial payers.